Business ❯ Corporate Strategy

Research and Development

Innovation Investment Product Development Market Expansion Cost Management Product Innovation Capital Expenditure Partnerships Product Pipeline Investment Trends

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

The purchases mark a strategic shift into vaccine-led prevention that Lilly says will move forward only after routine regulatory clearances.

Semtech Shares Surge After Strong Q1 Results and Bullish Q2 Guidance

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

Broadcom Shares Fall After Trump‑Xi Talks Leave China Chip Shipments Unclear

Moderna Jumps on Hantavirus Cruise-Ship Cluster as U.S. Repatriates 17 Citizens

L&T Launches Industrial Electronics Unit, Commissions Coimbatore Lines

TSMC Sets 2029 Targets for A13 and A12, Delaying High‑NA EUV

Lam Research Beats Q3 and Raises Outlook as Analysts Lift Targets

Chery Plans Small Cars for Europe, Starts Work on New Platform

Multiple Indian Drugmakers Win U.S. Clearance to Sell Farxiga Generic

XPeng Posts First Quarterly Profit, Guides to Sharp Q1 Slowdown

Legend Biotech Reports 66% Q4 CARVYKTI Sales Surge as Capacity Ramps and 2026 Profit Nears

Xiaomi Sets Yearly XRing Chip Cadence, Plots International AI Assistant

Xeris Biopharma Sets 2026 Revenue Outlook at $375–$390 Million, Targets H2 Start for XP-8121 Phase III

Apple Reportedly Taps Google Servers in Its Data Centers to Power Gemini‑Backed Siri Overhaul

MiniMax Revenue Jumps 159% on Overseas Demand as Net Loss Reaches $1.87 Billion

Japan Becomes Largest Shareholder in Rapidus With ¥100 Billion Injection as ¥267.6 Billion Round Closes

Leonardo DRS Reports 2025 Growth and Raises 2026 Guidance as Shares Surge

First Solar Secures U.S. License to Oxford PV’s Perovskite Patents

Perceptive Advisors Makes Praxis Its Largest Holding After Disclosing Big Q4 Buy